Literature DB >> 6762962

Vasoactive peptides in the lung, with special reference to vasoactive intestinal peptide.

S I Said.   

Abstract

Numerous biologically active peptides are present in normal lung. Some of these, like vasoactive intestinal peptide (VIP) and substance P, are neuropeptides that may function as neurotransmitters or neuromodulators. The activities of lung peptides include relaxation or contraction of airway and pulmonary vascular smooth muscle, modification of bronchial water and mucus secretion, and stimulation of adenylate cyclase activity. Much remains to be learned about active peptides in the lung: their full identities, their localization, their physiologic roles, and their participation in disease processes. One of these peptides, VIP, widely distributed in other organ systems, may mediate the nonadrenergic relaxation of airways and pulmonary vessels. It may also regulate bronchial secretion and, through its promotion of cyclic adenosine monophosphate accumulation in the lung, may modulate the immunologic release of mediators from mast cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6762962     DOI: 10.3109/01902148209069662

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  8 in total

1.  Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation.

Authors:  S G Farmer; J Togo
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

2.  Regulatory peptides in the respiratory system.

Authors:  P J Barnes
Journal:  Experientia       Date:  1987-07-15

3.  The third nervous system in the lung: physiology and clinical perspectives.

Authors:  P J Barnes
Journal:  Thorax       Date:  1984-08       Impact factor: 9.139

4.  Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography.

Authors:  P J Barnes; A Cadieux; J R Carstairs; B Greenberg; J M Polak; K Rhoden
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

5.  Vasoactive intestinal peptide in human nasal mucosa.

Authors:  J N Baraniuk; J D Lundgren; M Okayama; J Mullol; M Merida; J H Shelhamer; M A Kaliner
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Bronchodilator-mediated relaxation of normal and ovalbumin-sensitized guinea-pig airways: lack of correlation with lung adenylate cyclase activation.

Authors:  J F Burka; M H Saad
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

7.  Actin reorganization is involved in vasoactive intestinal peptide induced human mast cells priming to fraktalkine-induced chemotaxis.

Authors:  Amr E El-Shazly
Journal:  Int J Gen Med       Date:  2008-11-30

8.  Age-related changes in vasoactive intestinal polypeptide levels and distribution in the rat lung.

Authors:  P Geppetti; M De Rossi; M C Mione; D Renzi; F Amenta
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.